Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
Go back to Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026| (NASDAQ: CADL) | Delayed: 12.25 -0.35 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.60 | 52 Week High | $ | |||
| Open | $12.52 | 52 Week Low | $ | |||
| Day High | $12.78 | P/E | N/A | |||
| Day Low | $12.25 | EPS | $ | |||
| Volume | 363,442 | |||||
